Drug name - Narcan

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9629965 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(12 years from now)

US10085937 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(12 years from now)

US9480644 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(12 years from now)

US9775838 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(12 years from now)

US9561177 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(12 years from now)

US9707226 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(12 years from now)

US9468747 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(12 years from now)

US9211253 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(12 years from now)

Drugs and Companies using NALOXONE HYDROCHLORIDE ingredient

Market Authorisation Date: 18 November, 2015

Treatment: Use of naloxone hydrochloride for emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression.

Dosage: SPRAY, METERED;NASAL

More Information on Dosage
Strength Dosage Availability
2MG/SPRAY SPRAY, METERED;NASAL Discontinued
4MG/SPRAY SPRAY, METERED;NASAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.